Nick James is at the forefront of the battle against cancer. In his paper about targeted therapies (in Part 1: Microcosm: Tackling the big challenges in The New Optimists) he explains the latest cancer treatments, particularly the success, but also the cost of targeted molecular approaches to cancer treatment.
As Professor of Clinical Oncology at the University of Birmingham and the Queen Elizabeth Hospital Birmingham, Nick James’ current research focusses on urological tumours, and he leads a number of international trials. In 1994, he co-founded the leading patient website, CancerHelpUK which has won numerous awards.
He qualified from St Bartholomew’s Hospital with the principal class prize in medicine. After general training in London and Brussels, he undertook oncology training at Hammersmith, the Royal Marsden, St Marys and St Bartholomew’s Hospitals and at the Cancer Institute, Tokyo.
Tags: Cancer, molecular biology, Nick James, oncology, University of Birmingham